Musculoskeletal System Disorders Market Trends 2020, Share, Trends, Growth Factors, Segments and Geographic Overview

26/mag/2020 22:14:05 Market Research Future Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Market Highlights

According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of ~5.30% during the forecast period of 2019 to 2025 and was valued at USD 3837.7 million in 2018.


Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck.

The growth of global Musculoskeletal System Disorders Market trends is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are   expected to curb the growth of the global musculoskeletal system disorders market.

The global musculoskeletal system disorders market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of musculoskeletal system disorders and rising per capita healthcare expenditure. The musculoskeletal system disorders market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European musculoskeletal system disorders market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The musculoskeletal system disorders market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of musculoskeletal system disorders and rising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The musculoskeletal system disorders market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

Some of the key players in the global musculoskeletal system disorders market are AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan),  AstraZeneca (UK), Baxter (US), and GlaxoSmithKline PLC (UK).

Access Report Details @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

blog comments powered by Disqus è un servizio offerto da Factotum Srl